PMID- 37882711 OWN - NLM STAT- MEDLINE DCOM- 20231030 LR - 20231030 IS - 1007-8738 (Print) IS - 1007-8738 (Linking) VI - 39 IP - 10 DP - 2023 Oct TI - [Effects and mechanism of knocking down lncRNA H19 to inhibit lipid accumulation in human THP-1 cells-derived macrophages]. PG - 884-890 AB - Objective To investigate the effects of long noncoding RNA H19 on lipid accumulation of macrophages under high fat stress and its mechanism. Methods Human THP-1 cells-derived macrophages were incubated with ox-LDL, and the effects of H19 siRNA intervention on lipid accumulation was observed. The THP-1 cells were divided into control group (conventional culture), ox-LDL group, siRNA negative control (NC siRNA) combined with ox-LDL treatment group, and H19 siRNA combined with ox-LDL treatment group. Oil red O staining was used to determine the lipid accumulation in cells, and cholesterol concentration was analyzed by enzymatic method; ATP assay kit for detecting celluar ATP content; colorimetry was used to detect the levels of oxidative stress indicators and ELISA was used to detect the levels of monocyte chemoattractant protein-1 (MCP-1) in the cell supernatant. Western blot analysis was used to detect the protein expression of ATP binding cassette transporter A1 (ABCA1), peroxisome proliferator-activated receptor alpha (PPARalpha), peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) and nuclear factor kappaB p-p65 (NF-kappaB p-p65). Results Knockdown H19 significantly inhibited intracellular lipid accumulation, decreased total cholesterol (TC) and cholesterol ester (CE) content, and decreased CE/TC ratio. Knockdown H19 significantly alleviated cell damage including an increase in ATP content, a decrease in oxidative stress levels and a decrease in MCP-1 levels, which caused by high-fat stress. H19 siRNA upregulated expression of ABCA1, PPARalpha and PGC-1alpha in THP-1 derived macrophages, downregulated NF-kappaB signal pathway. Conclusion Knockdown H19 upregulates PGC-1alpha expression in THP-1 cells and downregulates NF-kappaB pathway, which promotes cholesterol reverse transport, reduces inflammatory reaction and inhibits lipid accumulation. FAU - Wang, Xuemei AU - Wang X AD - Department of Public Health, Xi'an Medical College; Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases & Institute of Basic and Translational Medicine, Xi'an Medical College, Xi'an 710021, China. FAU - Che, Yue AU - Che Y AD - Department of Public Health, Xi'an Medical College, Xi'an 710021, China. FAU - Wang, Jieying AU - Wang J AD - Department of Public Health, Xi'an Medical College; Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases & Institute of Basic and Translational Medicine, Xi'an Medical College, Xi'an 710021, China. FAU - Men, Ke AU - Men K AD - Department of Public Health, Xi'an Medical College, Xi'an 710021, China. *Corresponding author, E-mail: menke@foxmail.com. LA - chi PT - English Abstract PT - Journal Article PL - China TA - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi JT - Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology JID - 101139110 RN - 8L70Q75FXE (Adenosine Triphosphate) RN - 97C5T2UQ7J (Cholesterol) RN - 0 (NF-kappa B) RN - 0 (PPAR alpha) RN - 0 (RNA, Long Noncoding) RN - 0 (RNA, Small Interfering) RN - 0 (H19 long non-coding RNA) SB - IM MH - Humans MH - Adenosine Triphosphate MH - Cholesterol MH - *NF-kappa B MH - PPAR alpha MH - *RNA, Long Noncoding/genetics MH - RNA, Small Interfering/genetics MH - THP-1 Cells MH - *Macrophages/metabolism MH - *Lipid Metabolism EDAT- 2023/10/26 12:42 MHDA- 2023/10/27 06:42 CRDT- 2023/10/26 10:13 PHST- 2023/10/27 06:42 [medline] PHST- 2023/10/26 12:42 [pubmed] PHST- 2023/10/26 10:13 [entrez] PST - ppublish SO - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023 Oct;39(10):884-890.